His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
3SBio will receive a payment of $1.25 billion. Pfizer will also make a $100 million equity investment in 3SBio
Upgrades 2025 full-year CDMO sales and margin outlook
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
The new Zigly center features and offers comprehensive veterinary services
Subscribe To Our Newsletter & Stay Updated
